Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript - Thomson StreetEvents

Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript

Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript - Thomson StreetEvents
Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript
Published Jul 25, 2023
12 pages (7004 words) — Published Jul 25, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of TARS.OQ conference call or presentation 25-Jul-23 12:30pm GMT

  
Brief Excerpt:

...Good morning, and welcome to the approval webcast of XDEMVY, formally known as TP-03 for the treatment of Demodex blepharitis. Before we begin, I encourage everyone who has not launched the webcast to proceed to the Investors & News section of our website to find the link to this webcast and the related slides. As a reminder, this webcast is being recorded and a replay will be available on the Investor and News section of the Tarsus website later today. (Event Instructions) I'd like to draw your attention to slide 3, which contains our forward-looking language statement. We will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail. With me on today's webcast are Bobby Azamian, our Chief Executive Officer and Chairman; Aziz Mottiwala, our Chief...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Tarsus Pharmaceuticals Inc
Ticker
TARS.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Tarsus Pharmaceuticals Inc Q3 2024 Earnings Call Transcript – 2024-11-13 – US$ 54.00 – Edited Transcript of TARS.OQ earnings conference call or presentation 13-Nov-24 9:30pm GMT

Tarsus Pharmaceuticals Inc at UBS Ophthalmology Day (Virtual) Transcript – 2024-10-02 – US$ 54.00 – Edited Transcript of TARS.OQ presentation 2-Oct-24 1:00pm GMT

Tarsus Pharmaceuticals Inc Q2 2024 Earnings Call Transcript – 2024-08-08 – US$ 54.00 – Edited Transcript of TARS.OQ earnings conference call or presentation 8-Aug-24 8:30pm GMT

Tarsus Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript – 2024-06-10 – US$ 54.00 – Edited Transcript of TARS.OQ presentation 10-Jun-24 6:00pm GMT

Tarsus Pharmaceuticals Inc Q3 2023 Earnings Call Transcript – 2023-11-09 – US$ 54.00 – Edited Transcript of TARS.OQ earnings conference call or presentation 9-Nov-23 9:30pm GMT

Tarsus Pharmaceuticals Inc To Discuss Creating the Next Blockbuster Category in Eye Care Call Transcript – 2023-06-15 – US$ 54.00 – Edited Transcript of TARS.OQ conference call or presentation 15-Jun-23 3:30pm GMT

Tarsus Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of TARS.OQ presentation 7-Jun-23 6:30pm GMT

Tarsus Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript – 2023-03-15 – US$ 54.00 – Edited Transcript of TARS.OQ presentation 15-Mar-23 8:05pm GMT

Tarsus Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript – 2023-03-13 – US$ 54.00 – Edited Transcript of TARS.OQ presentation 13-Mar-23 3:20pm GMT

Tarsus Pharmaceuticals Inc To Discuss Revolutionizing Treatment For Demodex Blepharitis Patients Call Transcript – 2022-02-08 – US$ 54.00 – Edited Transcript of TARS.OQ conference call or presentation 8-Feb-22 5:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript" Jul 25, 2023. Alacra Store. May 03, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Tarsus-Pharmaceuticals-Inc-To-Discuss-XDEMVY-Approved-For-The-Treatment-Of-Demodex-Blepharitis-Call-T15669072>
  
APA:
Thomson StreetEvents. (2023). Tarsus Pharmaceuticals Inc To Discuss XDEMVY Approved For The Treatment Of Demodex Blepharitis Call Transcript Jul 25, 2023. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Tarsus-Pharmaceuticals-Inc-To-Discuss-XDEMVY-Approved-For-The-Treatment-Of-Demodex-Blepharitis-Call-T15669072>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.